Can an anti-inflammatory drug prevent urethral stricture recurrence?
Part of Kidney & urinary clinical trials.
This trial tests if taking a COX-2 inhibitor (a type of anti-inflammatory) after a procedure to widen a narrowed urethra can lower the chances of the narrowing coming back. It may help men with a short first-time stricture.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your stricture (narrowing) is 1.5 cm or shorter.
- This is your first or second time having this problem treated.
- You have not had a broken pelvis that damaged your urethra.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a balloon coated with a drug (paclitaxel) helps prevent the urethra from narrowing again after treatment. It may be an option for people whose stricture has come back after a prior procedure.
This trial tests a drug-coated balloon to open a narrowed part of the urethra (the tube that carries urine out of the body) in men who have not had this problem before. The balloon releases a medicine to help keep the area open.
This study collects information from patients who have had surgery for a urethral stricture, which is a narrowing in the tube that carries urine out of the body. Being part of this study helps doctors learn more about different surgical treatments and their outcomes.
This early-phase study tests whether taking an anti-inflammatory medicine around the time of ureter stent placement can improve outcomes for people with kidney stones. It looks for participants who are getting a stent after a scope procedure and who can follow strict medication and health rules.
This study looks at a surgical procedure (urethroplasty) for a condition where the urethra becomes narrowed (urethral stricture). If you join, you will be asked to consent to take part and follow the study rules.
This trial tests an oral medicine called RXC008 to see if it can help people with Crohn's disease who have narrowed areas in their small intestine (strictures). It aims to reduce symptoms and improve quality of life without needing surgery or dilation.
Hear when a new COX-2 Inhibitor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.